[Epigenetic changes in the promoter of the fragile histidine triad (FHIT) gene in human sebocytes under the influence of in vitro culture]. / Epigenetische Veränderungen am Promotor des fragilen Histidin-Trias(FHIT)-Gens in menschlichen Sebozyten unter dem Einfluss der In-vitro-Kultur.
Ophthalmologie
; 119(8): 813-819, 2022 Aug.
Article
de De
| MEDLINE
| ID: mdl-35254487
ABSTRACT
BACKGROUND:
Due to the lack of tumor suppressor function of the fragile histidine triad (FHIT) gene product, sebaceous gland carcinomas can develop.OBJECTIVE:
The model of the sebocyte cell line SZ95 was used to identify methylated CpG islands at the 5'-end of the FHIT gene and the decrease of gene expression as well as the increase of double-stranded (ds) DNA breaks were examined. MATERIAL ANDMETHODS:
Methylation, immunofluorescence analysis, promotor sequencing and treatment of SZ95 cells with 5azacytidine/trichostatin A (TSA).RESULTS:
The cultivation was accompanied by an increasing methylation of the CpG islands, a decrease of the FHIT gene expression and an accumulation of ds-DNA breaks. Treatment with 5azacytidine/TSA showed a decrease in DNA methylation and a re-expression of FHIT transcripts.DISCUSSION:
Epigenetic changes in the cellular genome are caused by in vitro cell culture. Consequently, a positive selection of sebocytes with an epigenetically inactivated FHIT locus occurs.Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Tumeurs des glandes sébacées
Limites:
Humans
Langue:
De
Journal:
Ophthalmologie
Année:
2022
Type de document:
Article